**Core tip:** We evaluated the feasibility of blood conservation pediatric cardiac surgery for all age groups and complexity levels in this retrospective study. We reviewed 356 patients who underwent cardiac surgery from 2010-2015. The patients were grouped into historical non-conservation (NC = 218) and blood conservation (BC = 138) cohorts. The blood conservation was performed by miniaturizing bypass circuit, changing the trigger point for transfusion and adapting protocols and guidelines accepted and implemented by the group. We demonstrated that the blood conservation practice can be performed safely in all ages and complexity levels by reducing cardiopulmonary bypass prime volume and institutional commitment to guidelines and practice of blood conservation cardiac surgery.

INTRODUCTION
============

There are accumulating evidences of the association of red blood cell (RBC) transfusion with adverse outcomes in both adult and pediatric patients undergoing cardiac surgery\[[@B1]-[@B5]\]. The increasing costs associated with blood transfusion and the need for preservation of limited blood supplies have mandated that RBC transfusion to be included as a quality indicator in cardiac surgery\[[@B6]\].

There are many blood conservation strategies available for children undergoing cardiac surgery depending on age and type of surgery. The main goal of blood conservation is to minimize exposure to allogeneic transfusion while maximizing the use of autologous red cells. Although, the effects and costs of all these methods have not yet been completely assessed, many of these strategies have been implemented in clinical practice collectively with great efficacy.

The purpose of this single-center study is to demonstrate the feasibility of blood conservation cardiac surgery practice across different age groups and complexity scores in congenital cardiac surgery.

MATERIALS AND METHODS
=====================

Retrospective analysis of 356 patients who underwent open heart surgery from 2010 to 2015 was investigated. The patients were categorized into blood conservation (BC) and non-conservation (NC) groups and subcategorized by their different age categories and the Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery Congenital Heart Surgery Mortality scores (STAT Complexity Scores) (Figure [1](#F1){ref-type="fig"}). The NC group (*n* = 218) underwent surgical procedures between 2010 and 2014 using conventional cardiopulmonary bypass (CPB) without utilizing intra-operative blood conservation methods or protocols. The BC group (*n* = 138) underwent surgical procedures between 2014 and 2015 by incorporating blood conservation equipment, techniques, and intra-operative guidelines for homologous RBC transfusion.
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The patients were analyzed for the amount of intraoperative RBC usage based on by their age categories and STAT complexity scores. There were no changes in clinical personnel as far as anesthesia, perfusion, intensive care, or cardiology care givers for both groups. A comprehensive database including demographics and intra-operative data was created for all the patients in the cohort using electronic and paper medical records. All the data collection was complete for the primary outcome of total intraoperative RBC usage in eligible patients undergoing cardiac surgery. The subjects requiring extracorporeal membrane oxygenator before or after surgery were excluded from the study groups. The institutional review board has exempted patients' consent and approved the study.

Intraoperative data included CPB and aortic cross-clamp (CC) times, hematocrit levels, and amount of homologous RBC transfusion. Preoperative hematocrit was measured by the preoperative work up in the core laboratory. Pre-bypass hematocrit was defined as the patient hematocrit measure by the blood gas analyzer prior to CPB. On bypass hematocrit was defined as hematocrit immediately after initiation of CPB. Post-bypass hematocrit was defined as the hematocrit prior to leaving the operating room suite. Intraoperative RBC transfusion was defined as the total amount of homologous RBC that the patient received from the time of arrival to the operating room until leaving the operating room, including prime volume for the CPB circuit. All the patients received irradiated and leukocyte depleted RBC based on the institutional blood bank protocol.

A strategic protocol by the surgeons, anesthesiology, and perfusion staff was formulated and agreed upon to achieve a reduction in hemodilution and trigger points for RBC transfusion. The formulation of the plan was divided into equipment and technique.

Equipment
---------

The Terumo System One Heart Lung Machine (Terumo Cardiovascular, Ann Arbor, MI) was modified and positioned close to the operating table to reduce tubing lengths. Four different arterio-venous loops were customized specific to the weight of the patient. The Terumo FX05 (weight \< 12 kg), FX15 (weight 12-75 kg), and FX25 (weight \> 75 kg) oxygenators with integrated arterial filter were utilized for the CPB runs. The Terumo Capiox CP50 was configured for the administration of cold cardioplegia and modified ultrafiltration (MUF). The Hemocor HPH 400TS (Minntech Corporation, Minneapolis, MN) was used to remove excess fluid from the circuit. The Haemonetics Cell Saver 5 (Haemonetics Corporation, Braintree, MA) has allowed for successful return of shed blood during and after surgery. Continuous arterial and venous blood gas monitoring (CDI 500 Terumo Cardiovascular, Ann Arbor, MI), and cerebral saturation monitoring (Somanetics INVOS 5100 C system, Somanetics Corporation, Troy, MI) provided additional hemodynamic information regarding adequacy of patient oxygenation and perfusion in order to tailor the need for blood transfusion. Utilization of point of care testing with i-STAT^®^ (Abbott Point of Care, Princeton, NJ) and the Hemochron Signature Elite (ITC, Edison, NJ) allowed us for micro sampling of 0.5 mL of patient blood throughout the operative management. The differences in perfusion equipment for the two eras are depicted in Table [1](#T1){ref-type="table"}.

###### 

Perfusion technique and equipment

  **Equipment and technique**                  **NC**                                **BC**
  -------------------------------------------- ------------------------------------- --------
  Integrated arterial filter with oxygenator   N                                     Y
  Retrograde arterial priming                  N                                     Y
  Modified ultrafiltration                     Y/N[1](#T1FN1){ref-type="table-fn"}   Y
  In-line blood gas analyzer                   N/Y[1](#T1FN1){ref-type="table-fn"}   Y
  Point of care blood micro sampling           Y                                     Y
  Cerebral saturation                          Y                                     Y
  Mixed venous saturation                      Y                                     Y
  Pediatric cell salvage                       N                                     Y

Some did and some did not. BC: Blood conservation; NC: Non-conservation; Y: Yes; N: No.

Perfusion technique
-------------------

The anesthesiology staff made every effort to minimize the amount of intravenous crystalloid infusion at the induction and throughout the operation to minimize hemodilution. Our current practice allows the primary perfusion staff to customize the patient circuitry with four available tubing packs and three oxygenators. These selections provided optimal circuit configuration based on patient size in order to decrease hemodilution while working safely within Food and Drug Administration (FDA) product specifications. The differences in priming volume between the two groups are demonstrated in Table [2](#T2){ref-type="table"}. The circuit is positioned closed to the operating bed while avoiding crowdedness around the surgeon and assistant. Incorporating vacuum assisted drainage has made it possible to increase the height of the oxygenator to the level of the patient decreasing the arterial and venous tubing length and significantly reducing hemodilution. Retrograde arterial and venous priming have been instrumental in displacing the crystalloid priming volume of the circuit with the patients' own blood reducing hemodilution effect at the initial stage of CPB.

###### 

Cardiopulmonary bypass circuit prime volume

  **Body weight (kg)**   **NC (mL)**   **BC (mL)**   **Reduction (%)**
  ---------------------- ------------- ------------- -------------------
  Neonate-12             400           160           60
  12-35                  600           445           26
  35-55                  800           520           35
  55-75                  1000          765           24
  \> 75                  1000          880           12

BC: Blood conservation; NC: Non-conservation.

We also aggressively ultrafiltrated the added crystalloid volume to the circuit to maintain an even fluid balance throughout the case. In addition, we performed arteriovenous MUF on all patients at the conclusion of the CPB. We routinely ultrafiltrated the remainder of the volume in the circuit and checked the hematocrit to ensure it was greater than or equal to the patient's most recent hematocrit before reinfusion. This whole blood containing clotting factors and the cell saver processed blood are given to the patient prior to leaving the operating room or taken to the intensive care unit for postoperative transfusion as needed.

Statistical analysis
--------------------

Standard descriptive statistics were used for patient demographic information. Values were calculated as mean ± SD. Continuous variables were compared between blood conservation and non-conservation groups using independent sample *t*-tests, for each of the 4 age groups (neonate, infant, child, and adolescent) and 5 STAT categories. *P* value \< 0.05 was considered to be statistically significant. SPSS software (IBM, Armonk, New York) was used for statistical analysis.

RESULTS
=======

There were a total of 356 patients with 218 patients in NC and 138 in BC arms. The breakdown of the patients in the ages and STAT categories for both groups are depicted in Figure [1](#F1){ref-type="fig"}. There were in general no statistically discernible differences in gender, weight, preoperative hematocrit, or pre-bypass hematocrit levels between the two groups across all ages and STAT categories. There was a trend toward longer bypass and cross clamp times in neonates, infants, and patients with STAT scores of 3 and 4 in NC cohort than BC counterpart, but did not consistently reach statistical significance (Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}). The neonates in NC group had higher post-bypass hematocrit (*P* = 0.001) despite comparable on-bypass hematocrit due to usage of larger volume of RBC (*P* \> 0.001). The infants in BC group were younger (*P* = 0.001) and had shorter CBP and CC times and much less RBC transfusion (*P* \< 0.001) despite comparable on-bypass hematocrits. The children in BC group had shorter bypass time (*P* = 0.04) but comparable CC time, on-bypass, and post-bypass hematocrit, but statistically less RBC usage (*P =* 0.002). Interestingly, the adolescence patients had higher on-bypass and post-bypass hematocrit (*P* \< 0.001) despite less RBC usage (*P* = 0.02) signifying the efficacy of our circuit and protocol to conserve blood (Table [3](#T3){ref-type="table"}). Overall, there was significantly less homologous RBC utilization across all age groups in BC than NC cohorts (Figure [2](#F2){ref-type="fig"}).
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###### 

Intraoperative variables in age categories for blood conservation and non-conservation cohorts

  **Operative variables**   **NC neonate *n* = 28 (12%)**   **BC neonate *n* = 23 (16%)**   ***P***    **NC infant *n* = 69 (32%)**   **BC infant *n* = 52 (38%)**   ***P***    **NC child *n* = 76 (35%)**   **BC child *n* = 29 (21%)**   ***P***   **NC adolescent *n* = 45 (21%)**   **BC adolescent *n* = 34 (25%)**   ***P***
  ------------------------- ------------------------------- ------------------------------- ---------- ------------------------------ ------------------------------ ---------- ----------------------------- ----------------------------- --------- ---------------------------------- ---------------------------------- ----------
  Average age (d)           10 ± 9                          12 ± 10                         0.08       187 ± 109                      139 ± 86                       0.001      1638 ± 806                    1730 ± 1012                   0.44      6280 ± 1977                        6671 ± 3103                        0.78
  Weight (kg)               3 ± 0.7                         3 ± 1                           0.94       6 ± 2                          6 ± 2                          0.3        19 ± 9                        20 ± 9                        0.49      60 ± 20                            57 ± 17                            0.19
  \% Male                   60%                             52%                             0.35       45%                            35%                            0.59       45%                           52%                           0.83      69%                                47%                                0.07
  Bypass (min)              161 ± 74                        136 ± 53                        0.15       124 ± 66                       85 ± 39                        \< 0.001   83 ± 48                       71 ± 45                       0.04      116 ± 63                           106 ± 59                           0.54
  Cross clamp (min)         75 ± 47                         75 ± 39                         0.99       74 ± 45                        45 ± 30                        \< 0.001   37 ± 38                       30 ± 32                       0.16      46 ± 53                            57 ± 46                            0.3
  Pre-operative Hct (%)     32 ± 2                          37 ± 5                          0.11       30 ± 5                         32 ± 7                         0.19       31 ± 4                        31 ± 5                        0.63      32 ± 7                             34 ± 4                             0.26
  Pre-bypass Hct (%)        36 ± 7                          35 ± 6                          0.19       30 ± 6                         31 ± 7                         0.89       33 ± 5                        31 ± 5                        0.1       34 ± 5                             33 ± 3                             0.54
  On-bypass Hct (%)         25 ± 3                          23 ± 3                          0.07       25 ± 3                         23 ± 3                         0.09       24 ± 3                        23 ± 3                        0.1       25 ± 3                             28 ± 3                             \< 0.001
  Post-bypass Hct (%)       47 ± 4                          34 ± 5                          0.001      35 ± 5                         34 ± 4                         0.3        31 ± 5                        32 ± 4                        0.75      28 ± 3                             34 ± 4                             \< 0.001
  Operative RBC (mL/kg)     236 ± 220                       97 ± 34                         0.01       90 ± 58                        49 ± 24                        \< 0.001   25 ± 26                       11 ± 10                       0.01      5 ± 13                             0.4 ± 2                            0.02
  RBC exposure (unit)       2 ± 0.5                         1.0 ± 0.2                       \< 0.001   1.6 ± 0.7                      0.8 ± 0.3                      \< 0.001   1.2 ± 0.9                     0.6 ± 0.6                     0.002     0.9 ± 2                            0.04 ± 0.2                         0.02

BC: Blood conservation; NC: Non-conservation; RBC: Red blood cell; Hct: Hematocrit.

###### 

Intraoperative variables in STAT categories for blood conservation and non-conservation cohorts

  **Operative variables**   **NC STAT 1 *n* = 118 (54%)**   **BC STAT 1 *n* = 73 (53%)**   ***P***    **NC STAT 2 *n* = 53 (24%)**   **BC STAT 2 *n* = 25 (18%)**   ***P***    **NC STAT 3 *n* = 29 (13%)**   **BC STAT 3 *n* = 15 (11%)**   ***P***    **NC TAT 4 *n* = 17 (8%)**   **BC STAT 4 *n* = 21 (15%)**   ***P***
  ------------------------- ------------------------------- ------------------------------ ---------- ------------------------------ ------------------------------ ---------- ------------------------------ ------------------------------ ---------- ---------------------------- ------------------------------ ----------
  Average age (d)           2419 ± 2667                     3088 ± 3498                    0.12       1500 ± 1947                    1012 ± 2176                    0.001      899 ± 1762                     619 ± 1659                     0.62       1724 ± 3559                  1447 ± 2817                    0.81
  Weight (kg)               27 ± 26                         29 ± 24                        0.53       17 ± 18                        15 ± 23                        0.58       11 ± 13                        9 ± 12                         0.65       16 ± 25                      14 ± 21                        0.81
  \% Male                   58%                             42%                            0.07       47%                            56%                            0.63       45%                            40%                            0.76       47%                          38%                            0.74
  Bypass (min)              82 ± 37                         74 ± 39                        0.2        127 ± 68                       94 ± 47                        0.03       185 ± 73                       131 ± 73                       0.02       155 ± 66                     132 ± 49                       0.22
  Cross clamp (min)         42 ± 29                         38 ± 31                        0.35       59 ± 55                        43 ± 43                        0.21       87 ± 64                        81 ± 45                        0.77       81 ± 58                      71 ± 37                        0.52
  Pre-operative Hct (%)     31 ± 4                          31 ± 4                         0.77       29 ± 5                         36 ± 8                         0.09       34 ± 11                        34 ± 6                         0.95       37 ± 8                       37 ± 7                         0.7
  Pre-bypass Hct (%)        31 ± 4                          30 ± 4                         0.62       35 ± 8                         33 ± 7                         0.39       35 ± 7                         32 ± 6                         0.14       35 ± 7                       35 ± 6                         0.7
  On-bypass Hct (%)         24 ± 3                          25 ± 4                         0.07       25 ± 4                         25 ± 4                         0.45       25 ± 4                         23 ± 3                         0.04       25 ± 3                       24 ± 4                         0.37
  Post-bypass Hct (%)       31 ± 4                          33 ± 3                         0.02       35 ± 5                         36 ± 4                         0.63       38 ± 5                         32 ± 3                         0.02       39 ± 12                      34 ± 5                         0.39
  Operative RBC (mL/kg)     36 ± 50                         21 ± 30                        0.02       66 ± 65                        40 ± 39                        0.03       115 ± 78                       53 ± 31                        0.03       219 ± 301                    64 ± 47                        0.05
  RBC exposure (unit)       0.9 ± 0.7                       0.5 ± 0.6                      \< 0.001   1.7 ± 1                        0.7 ± 0.4                      \< 0.001   2.2 ± 2.2                      0.8 ± 0.5                      \< 0.001   2.0 ± 0.9                    0.7 ± 0.4                      \< 0.001

BC: Blood conservation; NC: Non-conservation; RBC: Red blood cell; Hct: Hematocrit; STAT: Society of Thoracic Surgeon and European Association for Cardio-Thoracic Surgery Mortality Score.

The data was also further analyzed looking at the differences in complexity of the procedures based on STAT mortality scores (1, least complex - 5, more complex) (Table [4](#T4){ref-type="table"}). Patients in BC STAT 1 complexity level had higher post-bypass hematocrit (*P* = 0.02) with comparable on-bypass hematocrit despite less RBC usage (*P* \< 0.001). Patients in BC STAT 2 group were younger (*P* = 0.001) and had shorter bypass time (*P* = 0.03), which was also evident in BC STAT 3 category (*P* = 0.02). The BC STAT 1-4 categories in general had equivalent on-bypass hematocrit with less intraoperative RBC transfusion, which were all statistically significant. The STAT 5 groups could not be compared due to lack of sufficient subjects and power in NC group. Overall, there was significantly less homologous RBC utilization in BC group than NC group across all STAT complexity scores (Figure [3](#F3){ref-type="fig"}).
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DISCUSSION
==========

Blood conservation in pediatric cardiac surgery has been a panacea and quest of cardiac surgeon due to societal and institutional push for quality care. Despite its challenges, blood conservation cardiac surgery has been practiced in all stages of cardiac surgery in adult and pediatric in certain circumstances with a great success\[[@B7],[@B8]\]. There is a great variability in practice of blood transfusion for a given diagnostic code and complexity and pediatric population is no exception to the rule\[[@B9]\]. By far, pediatric patients undergoing cardiac surgery are exposed to more blood transfusion intra and post-operatively with no consensus or scientific evidence to what would be the optimal hematocrit level across different diagnosis and physiologic status\[[@B10]-[@B15]\].

In this retrospective study we have looked at the effectiveness of intra-operative blood conservation practice as compared to the historical non-conservation cohort. We have adapted novel techniques in CPB by miniaturizing and customizing the circuit to the patient's weight and using parameters such as mixed venous saturation, regional cerebral saturations, and serum lactic acid levels to tailor our decision about RBC transfusion. The bypass circuit was primed with the patients' own blood by performing retrograde arterial and venous priming once the aortic and venous cannulas were in place for majority of the operative procedures. We also performed aggressive hemofiltration during the bypass run and performed arteriovenous MUF after termination of CPB to remove excessive intravascular volume. Pediatric cell saver also was used throughout the operation and the salvaged blood was infused before leaving the operating room or immediately after arrival to the PICU. The efficacies of these conservation measures and practices have been reported by others as the result of greater emphasis that has recently been place in performing blood conservation cardiac surgery in pediatric population\[[@B16]-[@B19]\].

Our general trigger point for RBC transfusion was hematocrit of less than 21% for older age and low complexity category patients with biventricular physiology, and less than 25% for neonates, high complexity, and cyanotic univentricular patients. This protocol was followed as long other critical parameters of adequate systemic and cerebral perfusion remained within acceptable range. There were no patients in the blood conservation group whom experienced adverse neurologic events or other complications as the result of these changes in philosophy of RBC transfusion trigger points. We consistently maintained mixed venous saturation at greater than 60% and regional cerebral saturation at greater than the baseline level by increasing flow and cerebral vasodilation using pH-stat during cooling. The trend in serum lactate level after CPB was also used to determine the need for blood transfusion prior to leaving the operating room. Implementation of intraoperative transfusion algorithms in pediatric cardiac operations has also been shown to significantly reduce perioperative blood product use and morbidity\[[@B20]\]. Similarly, a comprehensive intraoperative blood-sparing approach that resulted in no transfusion in 25% of children undergoing cardiac operations compared with children who received a transfusion during the surgery demonstrated a shorter length of postoperative mechanical ventilation and a shorter PICU stay\[[@B21]\]. This has also been demonstrated that blood conservation in pediatric cardiac surgery was associated with a decrease in post-operative inotropic needs, days on ventilator, and length of stay in patients with biventricular physiology\[[@B22]\].

Historically, hemodilution during CPB was introduced to decrease homologous blood use and has been thought to improve microcirculatory flow\[[@B23],[@B24]\]. Hemodilution also potentially could reduce perfusion pressure, which increases the risk of an adverse neurologic outcome after CPB, increases cerebral blood flow and thereby increases the microembolic load to the brain, and reduces the oxygen carrying capacity of blood which might critically limit oxygen delivery to neurons and other cells\[[@B25]\]. Intraoperative implementation of hemodilution restriction prior to CPB to maintain the hematocrit close to preoperative hematocrit is paramount to a successful blood conservation cardiac surgery practice. By limiting crystalloid infusion during and after anesthesia induction, we significantly reduced the additional hemodilution that the patient will invariably face upon initiation of CPB. Having higher hematocrit prior to CPB will allow for retrograde priming of the bypass circuit and higher hematocrit during and after bypass. This was consistently achieved with our protocol and circuit modification throughout the operation despite lower RBC utilization signifying the efficacy of our conservation strategies across all ages and complexity levels.

This study carries some of the known limitations of a retrospective study design. It precludes accurate assessment of practice pattern and trigger points for RBC transfusion in the non-conservation group. There were also differences in surgeons as well as perfusion techniques and equipment that collectively could affect the variability in RBC transfusion trigger point and practices. Also, because of the lack of electronic charting and the absence of specific intraoperative measurements (*i.e*., cerebral and somatic saturation, serum lactic acid level) for non-conservation cohorts, we could not perform any statistical comparison for some variables between the two groups.

This study has shown that blood conservation in pediatric cardiac surgery is reproducible across different ages and complexity categories. Miniaturization of the CPB circuit, contemporary techniques and equipment, and institutional commitments and protocols were paramount in establishing a successful blood conservation program. Future improvements in perfusion technology and blood conservation protocols in association with additional prospective randomized trials will further capitalize our understanding of the benefit of blood conservation in pediatric cardiac surgery.

COMMENTS
========

Background
----------

Transfusion of homologous red blood cell has been associated with increase in morbidity in pediatric patients undergoing cardiac surgery. Pediatric cardiac surgical patients are at high risk of receiving blood transfusion as the result of cardiopulmonary bypass. Blood conservation surgery practice has been encouraged to reduced or eliminate related risks.

Research frontiers
------------------

The principle author has demonstrated previously that blood conservation in pediatric cardiac operations is associated with fewer ventilator days, lower inotropic scores, and shorter lengths of stay in patients with biventricular physiology. This study has expanded the safety and applicability of blood conservation cardiac surgery practice to all ages and complexity levels in patients with biventricular and univentricular hearts.

Innovations and breakthroughs
-----------------------------

Blood conservation cardiac surgery has been a quest of surgeons for a long time due to associated risks inherent to homologous blood transfusion. There are sporadic successful reports of blood conservation surgery in pediatric population with no concrete methodology or guidelines accepted by most practices to adapt and implement it in their practices. In most part, there are no accepted guidelines in what would be a safe hematocrit range during circulatory support in order to avoid cerebral and end organ ischemic injuries. This single-intuition retrospective study is the only study that has demonstrated blood conservation pediatric cardiac surgery can safely be performed in all ages and complexity categories in a wide spectrum of structural congenital cardiac defects.

Peer-review
-----------

The authors present their experience with implementing a blood conservation strategy for pediatric cardiac surgery at their institution. Overall, the manuscript is best categorized as a quality improvement evaluation.
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